The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Thymidylate synthase (TS) gene expression in patients with ALK positive (+) non-small cell lung cancer (NSCLC): Implications for therapy.
David R. Gandara
Consultant or Advisory Role - Response Genetics
Eric Huang
Employment or Leadership Position - Response Genetics
Sonal Desai
No relevant relationships to disclose
Philip C. Mack
No relevant relationships to disclose
Laurel Beckett
No relevant relationships to disclose
Craig Stephens
Employment or Leadership Position - Response Genetics
Stock Ownership - Response Genetics
Gary Zeger
Employment or Leadership Position - Response Genetics
Kathleen D. Danenberg
Stock Ownership - Response Genetics
Martin Karl Herbert Maus
Employment or Leadership Position - Response Genetics
Stock Ownership - Response Genetics
Tianhong Li
No relevant relationships to disclose